Inhibition of experimental atopic dermatitis by rhubarb (Rhizomes of Rheum tanguticum) and 5-lipoxygenase inhibition of its major constituent, Emodin

Phytotherapy Research

Volumn 25, Issue 5, 2011, Pages 755-759

  Jin, Jeong Ho ^a   Ngoc, Tran Minh ^b   Bae, Kihwan ^b   Kim, Yeong Shik ^c   Kim, Hyun Pyo ^a  

^a Kangwon National University   (South Korea)

^b Chungnam National University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

antiallergy; atopic dermatitis; emodin; lipoxygenase; Rheum tanguticum; rhubarb

Indexed keywords

ALCOHOL; ARACHIDONATE 5 LIPOXYGENASE; CLOBETASOL PROPIONATE; EMODIN; HAPTEN; IMMUNOGLOBULIN E; LEUKOTRIENE; RHUBARB EXTRACT;

ANGIOSPERM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG STRUCTURE; ENZYME INHIBITION; EOSINOPHIL COUNT; IC 50; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MAST CELL LEUKEMIA; MOUSE; NEUTROPHIL COUNT; NONHUMAN; RAT; RHEUM TANGUTICUM; RHIZOME; TREATMENT DURATION;

ADMINISTRATION, ORAL; ANIMALS; ANTHRAQUINONES; ANTI-ALLERGIC AGENTS; BLOOD CELL COUNT; BLOOD CELLS; DERMATITIS, ATOPIC; EMODIN; HAPTENS; IMMUNOGLOBULIN E; LIPOXYGENASE INHIBITORS; MALE; MICE; MODELS, ANIMAL; PLANT EXTRACTS; RATS; RHEUM; RHIZOME; SKIN;

ANIMALIA; MUS; RATTUS; RHEUM TANGUTICUM; RHEUM X HYBRIDUM;

EID: 79955536630     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3480     Document Type: Article

References (20)

1. Bae K,. 2000. The Medicinal Plants of Korea. Kyo-Hak Publishers: Seoul, 90.
2. Chari S, Clark-Loeser L, Shupack J, Washenik K,. 2001. A role for leukotriene antagonist in atopic dermatitis? Am J Clin Dermatol 2: 1-6. (Pubitemid 32405887)
3. Cuellar MJ, Giner RM, Recio MC, Manez S, Rios JL,. 2001. Topical anti-inflammatory activity of some Asian medicinal plants used in dermatological disorders. Fitoterapia 72: 221-229. (Pubitemid 32273462)
4. Elsner J, Escher SE, Forssmann U,. 2004. Chemokine receptor antagonists: a novel therapeutic approach in allergic disease. Allergy 59: 1243-1258. (Pubitemid 39506721)
5. Habif TP,. 1996. Atopic dermatitis. In Clinical Dermatology, 3rd edn, Habif TP, (ed.). Mosby-Year Book Inc.: St Louis, 100-121.
6. Huang HC, Chang JH, Tung SF, Wu RT, Foegh ML, Chu SH,. 1992. Immunosuppressive effect of emodin, a free radical generator. Eur J Pharmacol 211: 359-364.
7. Kim DH, Park EK, Bae EA, Han MJ,. 2000. Metabolism of rhaponticin and chrysophanol 8-O-β-D-glucopyranoside from the rhizome of Rheum undulatum by human intestinal bacteria and their anti-allergic actions. Biol Pharm Bull 23: 830-833. (Pubitemid 30484380)
8. Kuo YC, Meng HC, Tsai WJ,. 2001. Regulation of cell proliferation, inflammatory cytokine production and calcium mobilization in primary human T lymphocytes by emodin from Polygonum hypoleucum Ohwi. Inflamm Res 50: 73-82.
9. Leung DYM,. 1995. Atopic dermatitis: The skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 96: 302-319.
10. Leung DYM, Hirsch RL, Schneider L,. 1990. Thymopentin therapy reduces the clinical severity of atopic dermatitis. J Allergy Clin Immunol 85: 927.
11. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J,. 1997. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 9: 461-468.
12. Mossman T,. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods 65: 55-63.
13. Ngoc TM, Minh PTH, Hung TM, et al,. 2008. Lipoxygenase inhibitory constituents from rhubarb. Arch Pharm Res 31: 598-605.
14. Novak N,. 2009. New insights into the mechanism and management of allergic disease: atopic dermatitis. Allergy 64: 265-275.
15. Rubin P, Mollison KW,. 2007. Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids. Prostag Other Lipid Mediat 83: 188-197. (Pubitemid 46661257)
16. Rudikoff D, Lebwohl M,. 1998. Atopic dermatitis. Lancet 351: 1715-1721. (Pubitemid 28254541)
17. Suto H, Matsuda H, Mitsuishi K,. 1999. NC/Nga mice: a mouse model for atopic dermatitis. Int Arch Allergy Immunol 120: 70-75. (Pubitemid 29457367)
18. Suzuki R, Shimizu T, Kudo T, Yamashiro Y, Oshida K,. 2002. Effects of n-3 polyunsaturated fatty acids on dermatitis in NC/Nga mice. Prostag Leukot Essent Fatty Acids 66: 435-440. (Pubitemid 34785775)
19. Taniuchi S, Kojima T, Hara MK, et al,. 2001. Increased serum nitrate levels in infants with atopic dermatitis. Allergy 56: 693-695. (Pubitemid 32575446)
20. Tries S, Neupert W, Laufer S,. 2002. The mechanism of action of the new anti-inflammatory compound ML3000: inhibition of 5-LOX and COX-1/2. Inflamm Res 51: 135-143. (Pubitemid 34297852)